A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup ...

A simple blood test has been shown to be 98% accurate at distinguishing between patients with ALS and those without the ...

AcuraStem has received $4 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance the ...

It's gained greater awareness, thanks to grass roots initiatives. Learn about ALS based on a patient's experience and a ...

Ractigen's therapy candidate RAG-17 was safe across all tested doses and showed early signs of effectiveness in SOD1-ALS ...

A quarter of a million Americans are living with muscular dystrophy or a related neuromuscular disorder. It's the reason ...

A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion ...

Highly accurate determination of ALS using microRNA sequences will allow neurologists to make more rapid diagnoses, improving ...

People living with ALS, family members, friends, caregivers and anyone affected by the disease will come together for the ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...